Old Web
English
Sign In
Acemap
>
Paper
>
OA12.03 Activity of Crizotinib in MET or ROS1 Positive (+) NSCLC: Results of the AcSé Trial.
OA12.03 Activity of Crizotinib in MET or ROS1 Positive (+) NSCLC: Results of the AcSé Trial.
2018
Denis Moro-Sibilot
Nathalie Cozic
M. Perol
J Otto
J. Mazieres
P.J. Souquet
R. Bahleda
M Wislez
S. de Guibert
B. Mennecier
C. Chouaid
R. Sabatier
S. Bota
Radj Gervais
V. Verrièle
V. Haddad
G. Ferretti
Frédérique Nowak
C. Mahier Aït-Oukhatar
Gilles Vassal
Keywords:
ROS1
General surgery
Cancer research
Crizotinib
Medicine
Oncology
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
10
Citations
NaN
KQI
[]